MyGCH logo
  • image

 

 IMPORTANT DATES & INSTRUCTIONS 

01/04/2021 Submission Deadline

10/04/2021 Notification by email of Acceptance / Decline


The GGCH 2021, its first Virtual edition, is accepting Video Communications (on a surgical technique for example) or Video-Poster Communications (poster explained in video format)

As in previous editions, the presenting author has to be registered to the congress by this final notification deadline. Failure to meet deadlines will result in exclusion from any presentation or submission for publication.

Disclosure note: The submitting author is responsible for reporting the disclosure information for each named author. Disclosure of all authors is a step that must be completed prior to submission.


 GENERAL INSTRUCTIONS FOR ALL SUBMISSIONS 

1) Please note that the Global Congress on Hysteroscopy welcomes communications in the following categories:

  1. Submucosal Fibroids & Polyps.
  2. Hysteroscopy and Fertility.
  3. Hysteroscopy in Oncology.
  4. Hysteroscopy; Innovation, Simulation and Education.
  5. Hysteroscopy Complications.
  6. Hysteroscopy and Mullerian anomalies.
  7. Hysteroscopy and Contraception
  8. Hysteroscopic Instrumentation.
  9. Office Hysteroscopy, Vaginoscopy, and Pain Control.
  10. Other

2) The deadline for submission of Poster and Video Communications is Thursday, 1st April 2021, 11:59:59 p.m. CET. After this date, submissions will no longer be accepted.

3) All communications must be submitted electronically via e-mail (Dropbox, Wetransfer, or similar) to info@my-gch.com 

4) Institutional Review Board (IRB) Approval - IRB approval or waiver is required for submission of clinical research abstracts. You will be required during online submission to indicate whether your study has been IRB reviewed.

5) Every communication must cover these areas:

Aim: indicate the purpose and objective of the research, the hypothesis that was tested, or a description of the problem being analyzed or evaluated.

Method: describe the study period/setting/location, study design, data collection, and methods of analysis used.

Results: present as clearly and in as much detail as possible the findings/outcome of the study. Please summarize any specific results.

Conclusions: explain the significance of your findings/outcomes and future implications of the results.

6) For optimal video quality, presenters should follow these guidelines and specifications:

• Video MUST be in the formats of *.avi *.mov *.mpg as well as .mp4 and .WMV. The use of other formats may result in a loss of quality of the final output.

• Videos MUST have audio narration. All videos submitted without audio narration will not be considered for presentation. Background music is NOT allowed.

• Videos MUST include full disclosure information for ALL authors at the beginning of the video. All videos submitted without disclosures will not be considered for presentation.

• When a video is shot from its original source such as a camera, it should be recorded at the highest possible quality the camcorder can capture. The higher the resolution the better it will look on bigger screens. Also, it allows for room to degrade if the conversion is necessary.

• Videos with case-series require IRB approval or waiver at the time of video abstract submission.


 SPECIFIC INSTRUCTIONS FOR EACH TYPE OF COMMUNICATION 

1) Video Communication Submission (regarding a surgical technique):

Key Requirements:

• Each video should be a maximum of 3 minutes in length.

• The file size should be maximum 200 MB.

• Every registered participant may submit several individual videos.

• All personal data related to patient and/or examination (e.g. date, time, place, patient name, patient birth date, unique ID, examiner name or ID, institution) must be removed from videos before submission. Findings/diagnoses and markings such as arrows are allowed. If your image or video contains technical parameters, please make sure that they consist only of complete, recognizable data that are essential for understanding the video. Proof of patient consent must be provided if the patient can be identified.

2) Poster Communication Submission (poster explained in video format):

Key Requirements:

• Videos should be a maximum of 3 minutes in length.

• The content will be displayed in maximum 10 slides.

• The file size should be maximum 200 MB.

• Every registered participant may submit several individual videos.

• All personal data related to patient and/or examination (e.g. date, time, place, patient name, patient birth date, unique ID, examiner name or ID, institution) must be removed from videos before submission. Findings/diagnoses and markings such as arrows are allowed. If your image or video contains technical parameters, please make sure that they consist only of complete, recognizable data that are essential for understanding the video. Proof of patient consent must be provided if the patient can be identified.


 DISCLOSURE INSTRUCTIONS FOR ALL COMMUNICATIONS 

1) Reporting of Disclosures

This process is meant to ensure that anyone who is in a position to control the content of the education activity has disclosed to all relevant financial relationships with any commercial interest (see below for definitions) as it pertains to the content of the presentation. Should it be determined that a conflict of interest exists as a result of a financial relationship you may have, you will be contacted and methods to resolve the conflict will be discussed with you. In addition, full disclosures for all authors must be revealed by a slide at the beginning of the presentation. Failure or refusal to disclose or the inability to resolve the identified conflict may result in the withdrawal of the invitation to participate.

All authors for poster and video presentations are required to disclose ALL financial relationships with commercial interests involved in producing healthcare goods or services, active over the 12 MONTH period preceding the meeting whether or not this relationship is directly related to the material being presented. The abstract submitter must input the disclosure information for each named author prior to submission. Failure to comply with disclosure rules with complete honesty and openness will result in the individual forfeiting his or her right to present at the next congress. The organizing Committee has no issue with industrial affiliation, but they do with failure to disclose that affiliation. The audience MUST be given the tools with which to judge a presentation in light of the author’s interaction with the industry.

2) Commercial Interest

The ACCME defines a “commercial interest” as any proprietary entity producing health care goods or services, with the exemption of non-profit or government organizations and non-healthcare related companies.

3) Financial relationships

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefits. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received, or expected. Financial relationships of the person involved in the congress include financial relationships of a spouse or partner.


Please contact the Global Congress on Hysteroscopy 2021 at info@my-gch.com with any questions you may have.


Official APP now available

You can now download our official APP for iOS and Android



image Este sitio web usa cookies propias y de terceros. Si continúas navegando consideramos que aceptas su uso. Accept Read more »